BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30484072)

  • 1. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
    Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
    Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label use of prescription analgesics among hospitalized children in the United States.
    Carmack M; Berde C; Monuteaux MC; Manzi S; Bourgeois FT
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):474-481. PubMed ID: 32102118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
    García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
    An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.
    Smithburger PL; Buckley MS; Culver MA; Sokol S; Lat I; Handler SM; Kirisci L; Kane-Gill SL
    Crit Care Med; 2015 Aug; 43(8):1612-21. PubMed ID: 25855897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
    Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
    Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
    Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label Medication Prescribing Patterns in Pediatrics: An Update.
    Yackey K; Stukus K; Cohen D; Kline D; Zhao S; Stanley R
    Hosp Pediatr; 2019 Mar; 9(3):186-193. PubMed ID: 30745323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
    Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
    Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiological evaluation of off label and unlicensed prescription in pediatric intensive care units at tertiary care hospitals of Peshawar, Pakistan.
    Aamir M; Abid Shah M; Naheed Kauser T; Khan N; Mehmood I; Ali Khan J; Iqbal W
    Pak J Pharm Sci; 2023 Jan; 36(1):81-87. PubMed ID: 36967500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular Fentanyl and Ketorolac Associated with Superior Pain Control After Pediatric Bilateral Myringotomy and Tube Placement Surgery: A Retrospective Cohort Study.
    Stricker PA; Muhly WT; Jantzen EC; Li Y; Jawad AF; Long AS; Polansky M; Cook-Sather SD
    Anesth Analg; 2017 Jan; 124(1):245-253. PubMed ID: 27861435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
    Murphy DL; Lebin JA; Severtson SG; Olsen HA; Dasgupta N; Dart RC
    Drug Saf; 2018 Aug; 41(8):787-795. PubMed ID: 29582394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
    Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
    Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
    Kelly M; O'Connor R; Townsend L; Coghlan M; Relihan E; Moriarty M; Carr B; Melanophy G; Doyle C; Bannan C; O'Riordan R; Merry C; Clarke S; Bergin C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1150-1154. PubMed ID: 32687645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.